Will Jazz Pharma's Stock Awake With Q2 Earnings?
With Q2 earnings due Aug. 5, Jazz Pharmaceuticals is testing a new buy point. The maker of narcolepsy-related treatment Xyrem is in the No. 7-ranked Medical - Ethical Drugs industry group, which also includes top-rated drugmakers Horizon Pharmaceuticals and Valeant Pharmaceuticals.